Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse

Brain Research

Volumn 1382, Issue , 2011, Pages 315-320

  Zhou, Qing Hui ^a   Hui, Eric Ka Wai ^b   Lu, Jeff Zhiqiang ^b   Boado, Ruben J ^a,b   Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ArmaGen Technologies Inc   (United States)

Author keywords

Blood brain barrier; Erythropoietin; Monoclonal antibody; Parkinson's disease

Indexed keywords

CTFRMAB EPO FUSION PROTEIN; ERYTHROPOIETIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOCRIT; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT DURATION;

ANIMALS; BLOOD-BRAIN BARRIER; CHO CELLS; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; PARKINSONIAN DISORDERS; RECOMBINANT FUSION PROTEINS;

EQUIDAE; MUS;

EID: 79952538290     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.01.061     Document Type: Article

References (23)

1. Y. Aluf, J. Vaya, S. Khatib, Y. Loboda, S. Kizhner, and J.P.M. Finberg Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule Free Radic. Res. 44 2010 635 644
2. K.K. Anstrom, T. Schallert, M.T. Woodlee, A. Shattuck, and D.C. Roberts Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease Behav. Brain Res. 179 2007 183 191 (Pubitemid 46497454)
3. M. Bernaudin, H.H. Marti, S. Roussel, D. Divoux, A. Nouvelot, E.T. MacKenzie, and E. Petit A Potential role for erythropoietin in focal permanent cerebral ischemia in mice J. Cereb. Blood Flow Metab. 19 1999 643 651 (Pubitemid 30161216)
4. R.J. Boado, E.K. Hui, J.Z. Lu, and W.M. Pardridge Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horse J. Pharmacol. Exp. Ther. 333 2010 961 969
5. R.J. Boado, Y. Zhang, Y. Wang, and W.M. Pardridge Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse Biotechnol. Bioeng. 102 2009 1251 1258
6. R.J. Boado, Y.-F. Zhang, Y. Zhang, and W.M. Pardridge Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier Biotechnol. Bioeng. 96 2007 381 391 (Pubitemid 46232272)
7. M.A. Catania, M.C. Marciano, A. Parisi, A. Sturiale, M. Buemi, and G. Grasso Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils Eur. J. Pharmacol. 437 2002 147 150 (Pubitemid 34219475)
8. A.S. De Groot, L. Moise, J.A. McMurry, E. Wambre, L. Van Overtvelt, P. Moingeon, D.W. Scott, and W. Martin Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes" Blood 112 2008 3303 3311
9. S. Elliott, E. Pham, and I.C. Macdougall Erythropoietins: a common mechanism of action Exp. Hematol. 36 2008 1573 1584
10. L. Ferrucci, J.M. Guralnik, S. Bandinelli, R.D. Semba, F. Lauretani, A. Corsi, C. Ruggiero, W.B. Ershler, and D.L. Longo Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers Brit. J. Hemat. 136 2007 849 855 (Pubitemid 46348413)
11. A. Fu, Q.H. Zhou, E.K. Hui, J.Z. Lu, R.J. Boado, and W.M. Pardridge Neuroprotection in experimental stroke in the rat with an IgG-erythropoietin fusion protein Brain Res. 1360 2010 193 197
12. A. Fu, Q.H. Zhou, E.K. Hui, J.Z. Lu, R.J. Boado, and W.M. Pardridge Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood-brain barrier Brain Res. 1352 2010 208 213
13. A. Fu, E.K. Hui, J.Z. Lu, R.J. Boado, and W.M. Pardridge Neuroprotection in stroke in the mouse with intravenous erythropoietin-Trojan horse fusion protein Brain Res. 1369 2011 203 207
14. G. Grignaschi, E. Zennaro, M. Tortarolo, N. Calvaresi, and C. Bendotti Erythropoietin does not preserve motor neurons in a mouse model of familial ALS Amyotroph. Lateral Scler. 8 2007 31 35 (Pubitemid 46322937)
15. W.M. Pardridge, and R.J. Boado Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery Pharm. Res. 26 2009 2227 2236
16. V. Puskovic, D. Wolfe, J. Wechuck, D. Krisky, J. Collins, J.C. Glorioso, D.J. Fink, and M. Mata HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice Mol. Ther. 14 2006 710 715 (Pubitemid 44480759)
17. M. Sakanaka, T.C. Wen, S. Matsuda, S. Masuda, E. Morishita, M. Nagao, and R. Sasaki In vivo evidence that erythropoietin protects neurons from ischemic damage Proc. Natl Acad. Sci. USA 95 1998 4635 4640 (Pubitemid 28207965)
18. M. Sifringer, D. Brait, U. Weichelt, G. Zimmerman, S. Endesfelder, F. Brehmer, C. von Haefen, A. Friedman, H. Soreq, I. Bendix, B. Gerstner, and U. Felderhoff-Mueser Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain Brain Behav. Immun. 24 2010 792 799
19. L. Wei, B.H. Han, Ying Li, C.L. Keogh, D.M. Holtzman, and S.P. Yu Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats J. Pharmacol. Exp. Ther. 317 2006 109 116
20. Y.Q. Xue, L.R. Zhao, W.P. Guo, and W.M. Duan Intrastriatal adminstration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease Neuroscience 146 2007 1245 1258
21. Y. Zhang, F. Schlachetzki, Y. Zhang, R.J. Boado, and W.M. Pardridge Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental Parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter Hum. Gene Ther. 15 2004 339 350 (Pubitemid 38469776)
22. Y. Zhang, and W.M. Pardridge Near complete rescue of experimental Parkinson's disease with intravenous, non-viral GDNF gene therapy Pharm. Res. 26 2009 1059 1063
23. Q.H. Zhou, R.J. Boado, J.Z. Lu, E.K. Hui, and W.M. Pardridge Re-engineering erythropoietin as an IgG fusion protein that penetrates the blood-brain barrier in the mouse Mol. Pharm. 7 2010 2148 2155